Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma

Alexander Scholz, Patrick N. Harter, Sebastian Cremer, Burak H. Yalcin, Stefanie Gurnik, Maiko Yamaji, Mariangela Di Tacchio, Kathleen Sommer, Peter Baumgarten, Oliver Bähr, Joachim P. Steinbach, Jörg Trojan, Martin Glas, Ulrich Herrlinger, Dietmar Krex, Matthias Meinhardt, Astrid Weyerbrock, Marco Timmer, Roland Goldbrunner, Martina DeckertChristian Braun, Jens Schittenhelm, Jochen T. Frueh, Evelyn Ullrich, Michel Mittelbronn, Karl H. Plate, Yvonne Reiss*

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

121 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma'. Together they form a unique fingerprint.

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science